Press Release Anthos Therapeutics’ Novel Dual-Acting Factor XI/XIa Inhibitor, Abelacimab 150 mg, Demonstrated a 67% Reduction in the Primary Endpoint of Major or Clinically Relevant Non-Major Bleeding Compared with Rivaroxaban in Patients with Atrial Fibrillation 12 November 2023
Press Release AGCO Continues Technology Transformation to Become an Industry Leader in Smart Farming Solutions 12 November 2023
Press Release Diamond Estates Wines & Spirits Announces Update on Proposed Non-Brokered Financing 12 November 2023
Press Release Planet Launches First Pelican Tech Demonstration and 36 SuperDoves with SpaceX 11 November 2023
Press Release Alnylam Presents Positive Results from the KARDIA-1 Phase 2 Dose-Ranging Study of Zilebesiran, an Investigational RNAi Therapeutic in Development for the Treatment of Hypertension in Patients at High Cardiovascular Risk 11 November 2023
Press Release Spire Global Successfully Launched 11 Satellites on SpaceX’s Transporter-9 Mission 11 November 2023
Press Release LICY INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Li-Cycle Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit 11 November 2023
Press Release SEDG INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that SolarEdge Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Case 11 November 2023
